Proprietary Information and Assignment (Information) Agreements entered into with all executive officers
| Officer | Age | In this role | 2025 pay | Source |
|---|---|---|---|---|
|
Brent Pfeiffenberger
Also a director
President and Chief Executive Officer
|
48 | Not stated | Not reported | |
|
Chad Cowan
Chief Scientific Officer
|
Not stated |
Since 2024
2 years
|
$1,167,015 | |
|
Douglas Carr
SVP Finance & Operations
Title from the Form 4 dated Nov 3, 2026
|
Not stated | Not stated | Not reported | |
|
Gregory Russotti
See Remarks
Title from the Form 4 dated Sep 14, 2026
|
Not stated | Not stated | $912,320 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 27, 2026 · updated by the 8-K of Sep 9, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|---|
|
Brent Pfeiffenberger, Pharm.D.
Board chair, CEO
|
48 |
2023
3 years
|
Not stated | None stated | None stated | Paid as CEO | |
|
Alessandro Riva, M.D.
|
65 |
2021
5 years
|
Not stated |
Audit
Compensation
|
BeOne Medicines, Bicycle Therapeutics, PLC | $67,427 | |
|
Han Lee, Ph.D., M.B.A.
|
45 |
2025
1 year
|
Not stated |
Compensation
Audit
|
None stated | $40,241 | |
|
Kimberly Blackwell, M.D.
|
57 |
2021
5 years
|
Not stated |
Audit
Nominating and Corporate Governance · Chair
|
Monte Rosa Therapeutics, Inc. | $71,052 | |
|
Martin Murphy, Ph.D.
|
57 |
2025
1 year
|
Not stated | None stated | None stated | $40,335 | |
|
Daphne Quimi
|
60 |
2022
4 years
|
Not stated |
Audit · Chair
Nominating and Corporate Governance
|
Amylyx Pharmaceuticals, Inc. | $77,052 | |
|
Joseph Truitt
Joined Sep 9, 2026
|
- | - | Independent |
Compensation Committee
|
- | - | |
|
Timothy P. Walbert
Leaving at the meeting
|
Not stated | Not stated | Not stated |
Compensation
|
None stated | $63,052 |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
Proprietary Information and Assignment (Information) Agreements entered into with all executive officers
Indemnification agreements with each director and officer to indemnify for expenses, judgments, fines and settlements arising from service
Loading...